Fabre J, Balant L
Clin Pharmacokinet. 1976;1(2):99-120. doi: 10.2165/00003088-197601020-00002.
Patients with renal insufficiency often react abnormally to a number of drugs. Small doses that are safe under normal conditions may cause severe and even fatal side-effects. As a consequence, modification of the usual drug dosage of these drugs in required in renal insufficiency. Since the risk of retention concerns only those drugs which are mainly excreted by the kidney, it is possible to establish a mathematical relationship between glomerular filtration rate and the rate of drug elimination. These relationships serve as a basis for the determination of the proper dosage regimen for the individual patient. Such dosage adaptation for intermitten drug administration can be obtained by two methods and a series of compromises between them: (1) increase of the dosage interval without changing the dose, and (2) reduction of the does without changing the frequency of administration. One must however, not only consider inadequate drug elimination but also a number of other factors. Some of these modify the behaviour of the drug, such as hypoalbumineamia, which causes an increase of the unbound portion of the drug; anomalies of the volume of distribution, as found in patients with oedema; metabolic disturbance; alteration of absorption from the gastro-intestinal tract, etc. Other factors are related only indirectly to the pharmacokinetic behaviour of the drug. Frequently, there is an increased sensitivity to the undesirable side-effects of certain drugs in patients with renal insufficiency, causing the level of tolerance to be lowered compared with normal patients. Such an effect probably involves functional or morphological modifications of the drug receptors, or interaction with substance retained in renal insufficiency. Furthermore, drugs may accentuate the consequences of the nephropathy or have increased nephrotoxicity for those with diseased kidneys. It is with these important reservations that a critical analysis of the proposed methods of adapting drug dosage in renal insufficiency is presented. An appendix tabulates the effects of renal insufficiency on the behaviour of 117 drugs. Irrespective of the method used to calculate drug dosage, all patients with renal disease must be monitored closely, particularly for signs of unexpected drug toxicity.
肾功能不全患者常常对多种药物反应异常。在正常情况下安全的小剂量药物,在他们身上可能会引起严重甚至致命的副作用。因此,肾功能不全患者需要调整这些药物的常用剂量。由于药物潴留风险仅涉及那些主要经肾脏排泄的药物,所以可以在肾小球滤过率和药物消除率之间建立数学关系。这些关系为确定个体患者的合适给药方案提供了依据。对于间歇性给药的剂量调整可通过两种方法及二者之间的一系列折中来实现:(1)不改变剂量但延长给药间隔;(2)不改变给药频率但减少剂量。然而,必须不仅要考虑药物消除不足的情况,还要考虑许多其他因素。其中一些因素会改变药物的行为,比如低白蛋白血症会导致药物游离部分增加;分布容积异常,如水肿患者所见;代谢紊乱;胃肠道吸收改变等。其他因素仅与药物的药代动力学行为间接相关。肾功能不全患者常常对某些药物的不良副作用敏感性增加,与正常患者相比耐受性降低。这种效应可能涉及药物受体的功能或形态改变,或者与肾功能不全时潴留的物质相互作用。此外,药物可能会加重肾病的后果,或者对患病肾脏的患者具有更高的肾毒性。正是基于这些重要的保留意见,才对肾功能不全时调整药物剂量的提议方法进行批判性分析。附录列出了肾功能不全对117种药物行为的影响。无论采用何种方法计算药物剂量,所有肾病患者都必须密切监测,尤其是注意意外药物毒性的迹象。